规范PARP1/2和坦基拉斯:新兴的平行
Matthew Jessop1,2, Benjamin J Broadway1,2, Katy Miller1,2
1Division of Structural Biology, The Institute of Cancer Research (ICR), London, U.K.
The Biochemical journal
|August 23, 2024
概括
通过PARP和坦基拉酶合成的Poly-ADP-ribose (PAR) 对细胞过程至关重要. 了解坦基拉酶调节与PARP平行,为癌症等疾病的新药开发提供了信息.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 酶学 是一种酶学.
背景情况:
- ADP-ribosylation是一种关键的翻译后修饰,调节细胞功能.
- 聚-ADP-ribose (PAR) 是由PARP1,PARP2,坦基拉酶 (TNKS) 和TNKS2合成的,这些酶与人类疾病有关.
- PARP 抑制剂在临床上用于癌症,但由于机理性理解有限,坦基拉酶抑制剂面临发展障碍.
研究的目的:
- 为了比较PARP和tankyrase酶的结构功能关系.
- 阐明管理坦基拉酶活性和抑制的监管原则.
- 为了确定PARP和tankyrase之间的平行,以指导未来的治疗策略.
主要方法:
- 对PARP和tankyrases的现有结构功能研究进行比较分析.
- 对坦基拉酶抑制的分子影响和效应因子途径的审查.
- 检查调节机制,包括激活,自动PARylation,和全沟通.
主要成果:
- 在PARP和tankyrase酶的调节中存在着惊人的相似之处,尽管结构上的差异.
- 关键的调节原则包括低基底活性,通过组合激活,通过自动PARylation进行负面反,以及全沟通.
- 坦基拉酶的机制理解落后于PARP,阻碍了药物开发.
结论:
- 在PARP和tankyrase之间共享的调节原则为酶功能提供了洞察力.
- 对坦基拉酶机制的进一步研究对于克服临床开发挑战至关重要.
- 追究这些悬而未决的问题将有助于开发针对PARP和坦基拉酶家族酶的新疗法.
更多相关视频
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
3.9K
10:12Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
2.7K
相关概念视频
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
